Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

Condition:   Congestive Heart Failure Interventions:   Drug: OPC-61815 injection 8 mg;   Drug: OPC-61815 injection 16 mg Sponsor:   Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials